Clinic
East Valley Community Clinic, INC.
East Valley Community Clinic, INC. was paid $3.32M by Medicaid between Jan 2018 and Jan 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoEAST VALLEY COMMUNITY CLINIC, INC.
SAN JOSE, CA 95121
SAN JOSE, CA 95121
33aNPI1700830296assigned 05/20/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$3.32M
24GClaims90,188
24DCodes billed46
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#123 of 288
Median peer was paid$2.15M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,093 | $928K | |
| 2019 | 13,795 | $427K | |
| 2020 | 8,315 | $243K | |
| 2021 | 13,901 | $469K | |
| 2022 | 13,156 | $455K | |
| 2023 | 17,553 | $744K | |
| 2024incomplete | 1,375 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 10,668 | 10,076 | $746K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 14% | 573 | 568 | $477K |
| J3490 | Unclassified drugs | 8.4% | 9,428 | 7,889 | $279K |
| S4993 | Contraceptive pills for birth control | 7.2% | 2,743 | 2,709 | $238K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.0% | 1,235 | 1,232 | $232K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6.2% | 1,874 | 1,851 | $206K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.9% | 2,091 | 2,026 | $197K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.2% | 2,872 | 2,809 | $174K |
| 11981 | 3.6% | 645 | 642 | $119K | |
| 87806 | 3.4% | 6,126 | 5,204 | $111K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.7% | 5,578 | 5,334 | $91K |
| 99401 | 2.2% | 3,881 | 3,727 | $74K |
34 more codes
| 99201 | 1.8% | 686 | $60K | |
| 58300 | 1.4% | 629 | $47K | |
| 11976 | 1.2% | 762 | $38K | |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 59 | $33K |
| A4267 | Contraceptive supply, condom, male, each | <1% | 4,115 | $26K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,295 | $24K |
| 58301 | <1% | 823 | $20K | |
| 83986 | <1% | 7,112 | $16K | |
| S5000 | Prescription drug, generic | <1% | 2,296 | $16K |
| 81025 | <1% | 6,543 | $14K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 5,129 | $14K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 25 | $13K |
| 99000 | <1% | 4,799 | $11K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 16 | $10K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | <1% | 35 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,314 | $4K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 348 | $4K |
| 11982 | <1% | 247 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,284 | $2K |
| 81002 | <1% | 1,811 | $2K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 16 | $2K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 614 | $2K |
| S0190 | Mifepristone, oral, 200 mg | <1% | 46 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 32 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 72 | $805.85 |
| Q3014 | Telehealth originating site facility fee | <1% | 30 | $297.99 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 80 | $271.23 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 57 | $233.07 |
| 90686 | <1% | 16 | $93.96 | |
| Z7610 | <1% | 13 | $92.79 | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 59 | $81.15 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 30 | $30.68 |
| 90630 | <1% | 14 | $24.80 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDODSON-CRAWFORD, RAYROZ (CFO)
Parent organizationPLANNED PARENTHOOD MAR MONTE, INC.